NCT04355351View on ClinicalTrials.gov

Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)

NACompletedINTERVENTIONAL
Enrollment

303

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

December 4, 2021

Study Completion Date

June 22, 2022

Conditions
New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2
Interventions
OTHER

blood sampling

blood sampling done on hospital staff without sars-coV-2 symptoms

OTHER

additional blood tubes

Additionnal blood tube taken during the classical blood sampling in hospital

Trial Locations (3)

Unknown

Antibes Hospital, Antibes

Cannes Hospital, Cannes

06000

Nice Hospital, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04355351 - Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) | Biotech Hunter | Biotech Hunter